Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-10

Clinical Trial Update: Standard (180mg) Versus Double (360mg) Loading Dose of Ticagrelor in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating 180 mg versus 360 mg loading dose of ticagrelor in patients with ST-elevation myocardial infarction undergoing primary PCI; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TICAGRELOR (ticagrelor)

Snippet

Sponsor: University of Patras | Conditions: ST-elevation Myocardial Infarction | Phase 4 | Status: COMPLETED